DKSH and Clinova ink sales, marketing, distribution, logistics deal
DKSH Business Unit Healthcare, a partner for healthcare companies seeking to grow their business in Asia, will provide marketing, sales, distribution and logistics as well as regulatory services for Clinova’s range of ORS. Hydration Tablets across Asia.
Consumers in Hong Kong, Malaysia, Singapore and Thailand will have access to the products in pharmacies and hospitals as well as through e-commerce channels.
Clinova said ORS Hydration Tablets are made from a scientifically balanced formula of electrolytes, glucose and minerals.
It said the soluble tablet prevents dehydration and is particularly suitable for people with an active lifestyle, such as professional and recreational athletes.
“With a hot climate and a growing middle class placing high value on personal health, Asia is an increasingly attractive region for Clinova. Building our own Asian growth platform would be costly and time consuming. Hence, we rely on DKSH to quickly grow into new markets. DKSH’s ability to offer regulatory, commercial and distribution services across multiple channels and markets is invaluable to us,” said Charles Toomey, chairman APAC, Clinova.
Andrew Frye, business unit healthcare head at DKSH, said: companies like Clinova that are looking for growth are faced with a decision: “Will I invest my resources into building a platform or do I buy them?
“Outsourcing to DKSH provides a fast, low-risk and effective way to grow,” he said. “With more than 4,200 sales and marketing experts and a broad direct distribution network across health, consumer and e-commerce channels, DKSH’s growth platform is unmatched across Asia.”
